Skip to main content

FDA extends review of pegylated interferon for MS, Biogen says

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA extends review of pegylated interferon for MS, Biogen says

User login

Username

Password

Reset your password

Type	Lead	score